User profiles for Artur Isaev

Artur Isaev

Human Stem Cells Institute
Verified email at hsci.ru
Cited by 901

pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia

…, RE Kalinin, PG Shvalb, AA Isaev - Journal of …, 2015 - journals.sagepub.com
Effective treatment of chronic lower limb ischemia is one of the most challenging issues
confronting vascular surgeons. There are a number of choices available to the vascular surgeon. …

[HTML][HTML] Bringing a gene-activated bone substitute into clinical practice: From bench to bedside

…, NA Redko, VS Komlev, AA Isaev… - … in Bioengineering and …, 2021 - frontiersin.org
Bone grafting and reconstruction are still challenging in clinical practice because of the
limitations of bone autografts and the drawbacks of currently approved bone substitutes. We thus …

[HTML][HTML] Dermal fibroblasts as the main target for skin anti-age correction using a combination of regenerative medicine methods

A Zorina, V Zorin, A Isaev, D Kudlay… - Current Issues in …, 2023 - mdpi.com
This article includes the data from current studies regarding the pathophysiological mechanisms
of skin aging and the regenerative processes occurring in the epidermis and dermis at …

Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication

…, I Staroverov, R Kalinin, A Isaev - Therapeutic …, 2018 - journals.sagepub.com
Background: The effective treatment of chronic lower limb ischemia is one of the most
challenging issues confronting vascular surgeons. Current pharmacological therapies play an …

[HTML][HTML] Results of an international postmarketing surveillance study of pl-VEGF165 safety and efficacy in 210 patients with peripheral arterial disease

R Deev, I Plaksa, I Bozo, A Isaev - American Journal of Cardiovascular …, 2017 - Springer
Introduction The effective treatment of chronic lower limb ischemia is one of the most
challenging issues confronting vascular surgeons. Current pharmacological therapies play an …

[HTML][HTML] Safety and immunogenicity of betuvax-CoV-2, an RBD-Fc-based SARS-CoV-2 recombinant vaccine: preliminary results of the first-in-human, randomized …

…, SV Teplykh, RA Oseshnyuk, MA Stukova, AA Isaev… - Vaccines, 2023 - mdpi.com
COVID-19, being a life-threatening infection that evolves rapidly, remains a major public
health concern calling for the development of vaccines with broad protection against different …

[HTML][HTML] Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in …

…, PA Lebedev, SN Bardakov, AA Isaev… - International Journal of …, 2023 - mdpi.com
Dysferlinopathy treatment is an active area of investigation. Gene therapy is one potential
approach. We studied muscle regeneration and inflammatory response after injection of an …

[HTML][HTML] Diffuse colonies of human skin fibroblasts in relation to cellular senescence and proliferation

…, P Kopnin, IV Ozerov, S Leonov, A Isaev… - Aging (albany …, 2017 - ncbi.nlm.nih.gov
Abstract Development of personalized skin treatment in medicine and skin care may benefit
from simple and accurate evaluation of the fraction of senescent skin fibroblasts that lost …

[HTML][HTML] Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study

…, Y Raskina, A Novkunkskaya, P Talantov, A Isaev… - Scientific Reports, 2021 - nature.com
Properly conducted serological survey can help determine infection disease true spread. This
study aims to estimate the seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, …

[HTML][HTML] Glu20Ter Variant in PLEC 1f Isoform Causes Limb-Girdle Muscle Dystrophy with Lung Injury

…, IA Chekmaryeva, GD Dalgatov, AA Isaev - Frontiers in …, 2017 - frontiersin.org
Plectinopathies are orphan diseases caused by PLEC gene mutations. PLEC is encoding the
protein plectin, playing a role in linking cytoskeleton components in various tissues. In this …